Randomized Phase II Trial of Sunitinib/Gemcitabine or Sunitinib in Advanced Renal Cell Carcinoma with Sarcomatoid Features
The purpose of this study is to find out what effects sunitinib alone or the chemotherapy combination of sunitinib and gemcitabine has on a participant’s advanced kidney cancer with sarcomatoid features. Participants in this study have been diagnosed with advanced kidney cancer with sarcomatoid features that is not curable with surgery. Gemcitabine has been used for renal cell cancer in the past.
Back to Clinical Trials list